Geri-Care Pharmaceuticals, of Brooklyn, New York recalls
1 recall recorded since 2018, most recently on 26 January 2022. Status and classification are as published by the CPSC.
Recalls1
Ongoing (FDA)0
Terminated or completed0
Class I (FDA)0
Announced Consumer products
- Recall started
- 26 January 2022
- Reason
- The over-the-counter drug products contain regulated substances which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
- Remedy
- Consumers should immediately store the recalled products in a safe location out of sight and reach of children, and safely dispose of the recalled product as soon as is practicable. Contact Geri-Care Pharmaceuticals for a full refund or replacement over-the-counter drug product.
- Recall number
- 22060
CPSC recall notice
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.